OrbiMed’s SteadyMed Ltd STDY Stock Holding History

OrbiMed’s Portfolio STDY Stock Details STDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,246,196	Closed	-$19.1M	–	168
2018 Q2	$19.1M	Hold	4,246,196	–	–	0.23%	95
2018 Q1	$13.8M	Hold	4,246,196	–	–	0.17%	95
2017 Q4	$15.7M	Hold	4,246,196	–	–	0.2%	84
2017 Q3	$14.2M	Hold	4,246,196	–	–	0.14%	98
2017 Q2	$26.8M	Buy	4,246,196 +1,174,000	+38%	+$7.98M	0.28%	75
2017 Q1	$17.8M	Hold	3,072,196	–	–	0.2%	83
2016 Q4	$7.99M	Hold	3,072,196	–	–	0.1%	98
2016 Q3	$11M	Buy	+3,072,196	New	+$10.5M	0.13%	98

Other funds holding STDY

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Appleton Partners Boston, Massachusetts $1.43B AUM 22.6% 1-Year Est. Return

HCMT

Highland Capital Management (Tennessee) Memphis, Tennessee $1.89B AUM 33.93% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

TCOV

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

OrbiMed's STDY Position: Q3 2018 in Review

OrbiMed sold out of SteadyMed Ltd (STDY) in Q3 2018, closing a stake of 4,246,196 shares — an estimated $19.1M sold.

OrbiMed first reported a position in STDY in Q3 2016 and held it in 8 quarters. The position peaked at $26.8M in Q2 2017. 5 funds tracked by Wall St. Rank hold STDY as of Q3 2018.

OrbiMed reported no remaining SteadyMed Ltd position as of Q3 2018 after selling out during the quarter.
OrbiMed sold 4,246,196 SteadyMed Ltd shares in Q3 2018, an estimated $19.1M.
OrbiMed first reported a position in SteadyMed Ltd in Q3 2016 and held it in 8 quarters.
OrbiMed's SteadyMed Ltd position peaked at $26.8M in Q2 2017.
5 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2018.

Based on OrbiMed's 13F filing for Q3 2018, filed 14 Nov 2018.